BioSpark: An End-to-End Generative System for Biological-Analogical Inspirations and Ideation
Not on the map. Why?
Abstract (arXiv)
Nature is often used to inspire solutions for complex engineering problems, but achieving its full potential is challenging due to difficulties in discovering relevant analogies and synthesizing from them. Here, we present an end-to-end system, BioSpark, that generates biological-analogical mechanisms and provides an interactive interface to comprehend and synthesize from them. BioSpark pipeline starts with a small seed set of mechanisms and expands it using an iteratively constructed taxonomic hierarchies, overcoming data sparsity in manual expert curation and limited conceptual diversity in automated analogy generation via LLMs. The interface helps designers with recognizing and understanding relevant analogs to design problems using four main interaction features. We evaluate the biological-analogical mechanism generation pipeline and showcase the value of BioSpark through case studies. We end with discussion and implications for future work in this area.
Key facts. Cited by 4 papers in the map (data through 14 Oct 2026). First posted on arXiv 18 Dec 2023.
Builds on
No reference list yet.
Built on by
Citing papers per year: 2024: 1; 2025: 3.
4 papers.
- 2024Human-LLM Compound System for Scientific Ideation through Facet Recombination and Novelty Evaluationcited by 41
- 2025Literature-Grounded Novelty Assessment of Scientific Ideascited by 19
- 2025Inkspire: Supporting Design Exploration with Generative AI through Analogical Sketchingcited by 13
- 2025DesignWeaver: Dimensional Scaffolding for Text-to-Image Product Designcited by 6
- 2025Literature-Grounded Novelty Assessment of Scientific Ideas27 Jun 2025
- 2025DesignWeaver: Dimensional Scaffolding for Text-to-Image Product Design14 Feb 2025
- 2025Inkspire: Supporting Design Exploration with Generative AI through Analogical Sketching30 Jan 2025
- 2024Human-LLM Compound System for Scientific Ideation through Facet Recombination and Novelty Evaluation23 Sep 2024